{"schema":"hottub-news/prospects/v1","item":{"id":"n_5a6wtupcrldpvuc3ufkq","title":"Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products","title_en":null,"url":"https://www.manilatimes.net/2026/11/14/tmt-newswire/pr-newswire/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products/2469997","outlet":"The Manila Times","published":"2026-11-14T05:58:00Z","sponsored":false,"page":"https://hottub.news/articles/n_5a6wtupcrldpvuc3ufkq"},"prospects":[{"name":"The Manila Times","kind":"organization","role":"outlet","website":"https://manilatimes.net/","entity":"wikidata:Q1573100","source":"https://www.manilatimes.net/2026/11/14/tmt-newswire/pr-newswire/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products/2469997","note":"Published: Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products (2026-11-14)","reason":"Published “Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products” on 2026-11-14","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=The%20Manila%20Times&kind=organization&website=https%3A%2F%2Fmanilatimes.net%2F&source=https%3A%2F%2Fwww.manilatimes.net%2F2026%2F11%2F14%2Ftmt-newswire%2Fpr-newswire%2Fzai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products%2F2469997&entity=wikidata%3AQ1573100&note=Published%3A%20Zai%20Lab%20Announces%20First-Time%20Inclusion%20of%20KarXT%20and%20VYVGART%20Hytrulo%C2%AE%20in%20China%27s%202026%20National%20Reimbursement%20Drug%20List%2C%20Expanding%20Access%20to%20Key%20Growth%20Products%20%282026-11-14%29","propose":{"name":"The Manila Times","kind":"organization","reason":"Published “Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products” on 2026-11-14","requestId":"news:n_5a6wtupcrldpvuc3ufkq:wikidata:Q1573100:2755907a","website":"https://manilatimes.net/","sourceUrl":"https://www.manilatimes.net/2026/11/14/tmt-newswire/pr-newswire/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products/2469997","entity":"wikidata:Q1573100"}}],"someone_else":{"source":"https://www.manilatimes.net/2026/11/14/tmt-newswire/pr-newswire/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products/2469997","note":"In the news: Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products (The Manila Times, 2026-11-14)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}